The global microfluidic market is expected to grow at a CAGR of 19.6% from 2020 to reach USD 46.90 billion by 2027. The growth is primarily driven by technological advancements, fast returns on investment, improved portability via microfluidic chip miniaturization, increasing data precision & accuracy and high demand for POC testing. However, complex regulatory standards, difficulty in incorporating microfluidics technology pose significant challenge.
By Product: Microfluidic-based devices segment to register highest CAGR
Microfluidic-based devices segment accounted for the fastest growth of Microfluidic market by product in the forecast period. The growth can be primarily attributed to increasing adoption of microfluidic devices, rapid testing and low consumption of sample and reagent.
By Application: In-vitro diagnostics segment to grow at highest rate
On the basis of application, microfluidics market is segmented into in-vitro diagnostics, pharmaceutical life science research & manufacturing and therapeutics. The in-vitro diagnostics segment is expected to register highest CAGR during the forecast period. The growth can be mainly attributed to high adoption for laboratory & POC testing, growing demand, prevalence of chronic illnesses and increased need for miniaturized and portable diagnostic device.
By End User: Microfluidic market held largest market share in hospitals & diagnostic centres in end user segment
Based on the end user segregation, hospitals & diagnostic centres accounted for largest market share in forecast period. The growth can be ascribed by increasing demand for microfluidic technique, technological advancements and faster diagnosis.
By Region: North America to account for largest share of regional market
In 2020, North America accounted for the largest share of microfluidic market. The largest share of this regional segment is mainly due to increased demand for POC testing, prevalence of chronic illness, government initiatives and increased focus on research projects on proteins, biomolecules and genes. APAC is expected to witness lucrative growth due to increased demand for medical diagnostics.
Competitive Scenario
- Danaher Corporation (US)
- Thermo Fisher Scientific (US)
- PerkinElmer Inc. (US)
- Agilent Technologies (US)
- Bio-Rad Laboratories Inc. (US)
- Becton, Dickinson and Company (US)
- F. Hoffmann-La Roche (Switzerland)
- Illumina, Inc. (US)
- Fluidigm Microfluidics (US)
- Abbott Laboratories (US)
- QIAGEN (Netherlands)
- Parker-Hannifin Corporation (US)
- Fluigent SA (France)
- Idex Corporation (US)
- Camozzi Automation Spa Società Unipersonale (Italy)
- Gems Sensors and Control (US)
- Aignep S.P.A. (Italy)
- SMC Corporation (Japan)
- Dolomite Microfluidics (UK)
- Cellix Ltd. (Ireland)
- Elveflow (France)
- Microfluidic ChipShop (Germany)
- Micronit Microtechnologies (Netherlands)
- and MicroLiquid (Spain).
1. Introduction
2. Research Methodology
3. Executive Summary
4. Premium Insights
5. Market Overview
5.1. Introduction
5.2. Market Dynamics
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Opportunities
5.2.4. Challenges
5.3. COVID-19 Impact of the Microfluidics Market
6. Industry Insights
6.1. Introduction
6.2. Industry Trends
7. Global Microfluidic Market, By Product, 2019-2027 (USD Million)
7.1. Introduction
7.2. Microfluidic-based devices
7.3. Microfluidic components
8. Global Microfluidic Market, By Application, 2019-2027 (USD Million)
8.1. In-vitro diagnostics
8.2. Pharmaceutical, life science research & manufacturing
8.3. Therapeutics
9. Global Microfluidic Market, By End User, 2019-2027 (USD Million)
9.1. Hospitals & diagnostic centres
9.2. Academic & research institutes
9.3. Pharmaceutical & biotechnology companies
10. Global Microfluidic Market, By Geography, 2019-2027 (USD Million)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Rest of Asia-Pacific
10.4. Rest of the World
10.4.1. Latin America
10.4.2. Middle East & Africa
11. Competitive Landscape
11.1. Introduction
11.2. Market Share Analysis
11.3. Competitive Situation and Trends
11.3.1. Product Launches
11.3.2. Partnerships, Collaborations and Agreements
11.3.3. Acquisitions
11.3.4. Expansions
11.3.5. Other Developments
12. Company Profiles
12.1. Danaher Corporation (US)
12.2. Thermo Fisher Scientific (US)
12.3. PerkinElmer Inc. (US)
12.4. Agilent Technologies (US)
12.5. Bio-Rad Laboratories, Inc. (US)
12.6. Becton, Dickinson and Company (US)
12.7. F. Hoffmann-La Roche (Switzerland)
12.8. Illumina, Inc. (US)
12.9. Fluidigm Microfluidics (US)
12.10. Abbott Laboratories (US)
12.11. QIAGEN (Netherlands)
12.12. Parker-Hannifin Corporation (US)
12.13. Fluigent SA (France)
12.14. Idex Corporation (US)
12.15. Camozzi Automation Spa Società Unipersonale (Italy)
12.16. Gems Sensors and Control (US)
12.17. Aignep S.P.A. (Italy)
12.18. SMC Corporation (Japan)
12.19. Dolomite Microfluidics (UK)
12.20. Cellix Ltd. (Ireland)
12.21. Elveflow (France)
12.22. Microfluidic ChipShop (Germany)
12.23. Micronit Microtechnologies (Netherlands)
12.24. MicroLiquid (Spain)
13. Appendix
13.1. Discussion Guide
13.2. Available Customizations
13.3. Related Reports
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
